NDC 70518-1898

Clopidogrel

Clopidogrel Bisulfate

Clopidogrel is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Clopidogrel Bisulfate.

Product ID70518-1898_8285830a-32b9-cce8-e053-2991aa0a88d6
NDC70518-1898
Product TypeHuman Prescription Drug
Proprietary NameClopidogrel
Generic NameClopidogrel Bisulfate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-02-22
Marketing CategoryANDA / ANDA
Application NumberANDA090540
Labeler NameREMEDYREPACK INC.
Substance NameCLOPIDOGREL BISULFATE
Active Ingredient Strength75 mg/1
Pharm ClassesDecreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70518-1898-0

30 TABLET, FILM COATED in 1 BLISTER PACK (70518-1898-0)
Marketing Start Date2019-02-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-1898-0 [70518189800]

Clopidogrel TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090540
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-22

Drug Details

Active Ingredients

IngredientStrength
CLOPIDOGREL BISULFATE75 mg/1

OpenFDA Data

SPL SET ID:3e2539c1-a6ad-4d60-944c-c2e7aa70ce45
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309362
  • Pharmacological Class

    • Decreased Platelet Aggregation [PE]
    • P2Y12 Platelet Inhibitor [EPC]
    • P2Y12 Receptor Antagonists [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]